Home › Funds › RIVERBRIDGE PARTNERS LLC › RGEN

RIVERBRIDGE PARTNERS LLC position in RGEN

Repligen Corp · Health Care

RIVERBRIDGE PARTNERS LLC reported holding 166,046 shares of RGEN (Repligen Corp) in its Q3 2026 13F filing — a position valued at US$31.9M, representing 0.94% of its reported portfolio and ranking #34 among its reported holdings. RIVERBRIDGE PARTNERS LLC has disclosed RGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)166.05K sh
Reported value held$31.92M
Portfolio Weight0.94%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How RIVERBRIDGE PARTNERS LLC's RGEN position evolved

RIVERBRIDGE PARTNERS LLC first disclosed a stake in RGEN in Q3 2023 at 459,761 shares (US$73.1M). The position peaked in Q1 2024 at 445,168 shares, worth US$81.9M. Across 13 filings, RIVERBRIDGE PARTNERS LLC increased the stake 1 time(s), trimmed it 11 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 166,046 shares valued at US$31.9M — a reduction of -6,461 shares quarter over quarter.. Notable position changes include a 33% trim in Q2 2026 (shares rose 41% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 459.76K $73.11M New
Q4 2023 450.94K $81.08M Reduce
Q1 2024 445.17K $81.88M Reduce
Q2 2024 527.87K $66.54M Add
Q3 2024 500.98K $74.56M Reduce
Q4 2024 455.10K $65.51M Reduce
Q1 2025 422.10K $53.71M Reduce
Q2 2025 368.08K $45.78M Reduce
Q3 2025 343.44K $45.91M Reduce
Q4 2025 313.37K $51.35M Reduce
Q1 2026 258.48K $30.45M Reduce
Q2 2026 172.51K $23.54M Reduce
Q3 2026 166.05K $31.92M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGEN and 13F data

RGEN (Repligen Corp) is a Health Care company. 33 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$536.3M), Maverick Capital (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGEN

All RGEN fund holders →

FAQ

How long has RIVERBRIDGE PARTNERS LLC held RGEN?

RIVERBRIDGE PARTNERS LLC has disclosed RGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is RIVERBRIDGE PARTNERS LLC's current position in RGEN?

As of Q3 2026, RIVERBRIDGE PARTNERS LLC holds 166.05K shares of RGEN (Repligen Corp), valued at $31.92M, representing 0.94% of its reported portfolio and ranking #34.

Has RIVERBRIDGE PARTNERS LLC been buying or selling RGEN?

In the latest 13F filing (Q3 2026), RIVERBRIDGE PARTNERS LLC reduced its position in RGEN. The position peaked in Q1 2024 at 445.17K shares.

Which other funds hold RGEN?

Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick Capital, MAVERICK CAPITAL LTD, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.